(AIP) Arteris - Overview
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 751m USD | Total Return: 175.8% in 12m
Avg Trading Vol: 6.86M USD
Peers RS (IBD): 88.0
EPS Trend: 57.7%
Qual. Beats: 2
Rev. Trend: 81.4%
Qual. Beats: 2
Arteris, Inc. (NASDAQ: AIP) supplies semiconductor system-on-chip (SoC) intellectual property that enables on-chip communication and security across a broad geographic footprint, serving automotive, communications, enterprise computing, consumer electronics, and industrial customers.
In its latest fiscal quarter (Q4 2023), Arteris posted revenue of $61.2 million, an 18% year-over-year increase, and held $120 million in cash and short-term investments, underscoring a strong balance sheet. The company’s NoC IP portfolio-highlighted by FlexGen, FlexNoC, FlexWay, and the cache-coherent Ncore-has benefited from the rapid adoption of chiplet-based designs, a segment projected to grow at a 30% CAGR through 2027. Additionally, a new multi-year licensing agreement with a leading automotive semiconductor supplier expands Arteris’s exposure to the EV-driven automotive SoC market, which analysts expect to outpace overall semiconductor growth.
For a deeper dive into the valuation and risk profile, you might find it useful to explore ValueRay’s analysis.
- Semiconductor industry growth drives IP licensing revenue
- Automotive sector demand boosts Network-on-Chip adoption
- Global economic slowdown impacts chip design spending
- Competition from in-house IP development limits market share
| Net Income: -34.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 5.63 > 1.0 |
| NWC/Revenue: 13.02% < 20% (prev 16.98%; Δ -3.96% < -1%) |
| CFO/TA 0.06 > 3% & CFO 6.73m > Net Income -34.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.7m) vs 12m ago 8.85% < -2% |
| Gross Margin: 90.23% > 18% (prev 0.90%; Δ 8.93k% > 0.5%) |
| Asset Turnover: 63.82% > 50% (prev 54.39%; Δ 9.44% > 0%) |
| Interest Coverage Ratio: -163.1 > 6 (EBITDA TTM -28.1m / Interest Expense TTM 193k) |
| A: 0.08 (Total Current Assets 82.4m - Total Current Liabilities 73.2m) / Total Assets 115.0m |
| B: -1.49 (Retained Earnings -171.6m / Total Assets 115.0m) |
| C: -0.28 (EBIT TTM -31.5m / Avg Total Assets 110.6m) |
| D: -1.32 (Book Value of Equity -171.4m / Total Liabilities 129.7m) |
| Altman-Z'' Score: -7.64 = D |
| DSRI: 0.76 (Receivables 19.2m/20.8m, Revenue 70.6m/57.7m) |
| GMI: 0.99 (GM 90.23% / 89.67%) |
| AQI: 0.79 (AQ_t 0.22 / AQ_t-1 0.28) |
| SGI: 1.22 (Revenue 70.6m / 57.7m) |
| TATA: -0.36 (NI -34.7m - CFO 6.73m) / TA 115.0m) |
| Beneish M-Score: -3.57 (Cap -4..+1) = AAA |
Over the past week, the price has changed by +10.24%, over one month by +12.48%, over three months by +12.14% and over the past year by +175.76%.
- StrongBuy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Wallstreet Target Price | 20.3 | 23.2% |
| Analysts Target Price | 20.3 | 23.2% |
P/B = 56.0391
Revenue TTM = 70.6m USD
EBIT TTM = -31.5m USD
EBITDA TTM = -28.1m USD
Long Term Debt = 452k USD (from longTermDebt, last quarter)
Short Term Debt = 2.40m USD (from shortTermDebt, last quarter)
Debt = 9.08m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -24.8m USD (from netDebt column, last quarter)
Enterprise Value = 705.1m USD (750.7m + Debt 9.08m - CCE 54.6m)
Interest Coverage Ratio = -163.1 (Ebit TTM -31.5m / Interest Expense TTM 193k)
EV/FCF = 131.9x (Enterprise Value 705.1m / FCF TTM 5.34m)
FCF Yield = 0.76% (FCF TTM 5.34m / Enterprise Value 705.1m)
FCF Margin = 7.57% (FCF TTM 5.34m / Revenue TTM 70.6m)
Net Margin = -49.23% (Net Income TTM -34.7m / Revenue TTM 70.6m)
Gross Margin = 90.23% ((Revenue TTM 70.6m - Cost of Revenue TTM 6.89m) / Revenue TTM)
Gross Margin QoQ = 90.76% (prev 89.86%)
Tobins Q-Ratio = 6.13 (Enterprise Value 705.1m / Total Assets 115.0m)
Interest Expense / Debt = 0.59% (Interest Expense 54.0k / Debt 9.08m)
Taxrate = 21.0% (US default 21%)
NOPAT = -24.9m (EBIT -31.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.13 (Total Current Assets 82.4m / Total Current Liabilities 73.2m)
Debt / Equity = -0.62 (negative equity) (Debt 9.08m / totalStockholderEquity, last quarter -14.6m)
Debt / EBITDA = 0.88 (negative EBITDA) (Net Debt -24.8m / EBITDA -28.1m)
Debt / FCF = -4.64 (Net Debt -24.8m / FCF TTM 5.34m)
Total Stockholder Equity = -9.61m (last 4 quarters mean from totalStockholderEquity)
RoA = -31.42% (Net Income -34.7m / Total Assets 115.0m)
RoE = 361.6% (negative equity) (Net Income TTM -34.7m / Total Stockholder Equity -9.61m)
RoCE = 343.8% (negative capital employed) (EBIT -31.5m / Capital Employed (Equity -9.61m + L.T.Debt 452k))
RoIC = 328.3% (negative operating profit) (NOPAT -24.9m / Invested Capital -7.58m)
WACC = 14.99% (E(750.7m)/V(759.7m) * Re(15.17%) + D(9.08m)/V(759.7m) * Rd(0.59%) * (1-Tc(0.21)))
Discount Rate = 15.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.43%
[DCF] Terminal Value 46.03% ; FCFF base≈5.34m ; Y1≈3.51m ; Y5≈1.60m
[DCF] Fair Price = 0.87 (EV 14.9m - Net Debt -24.8m = Equity 39.7m / Shares 45.5m; r=14.99% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 57.67 | EPS CAGR: 12.94% | SUE: 3.46 | # QB: 2
Revenue Correlation: 81.44 | Revenue CAGR: 15.44% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-06-30): EPS=-0.06 | Chg7d=-0.007 | Chg30d=-0.007 | Revisions Net=-1 | Analysts=4
EPS current Year (2026-12-31): EPS=-0.17 | Chg7d=-0.027 | Chg30d=-0.027 | Revisions Net=-1 | Growth EPS=+50.0% | Growth Revenue=+29.0%
EPS next Year (2027-12-31): EPS=0.10 | Chg7d=-0.040 | Chg30d=-0.020 | Revisions Net=+1 | Growth EPS=+162.6% | Growth Revenue=+19.5%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)